Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer.

Wan-Ling Liu,Yong-Qu Zhang,Xiang-Jie Luo,Yuan-Yuan Zhu,Liang Song,Zi-He Ming,Li-Xin Zhang, Meng-Jun Li,Rui-Chan Lv,Guo-Jun Zhang,Min Chen

International journal of nanomedicine（2023）

引用 0|浏览1

暂无评分

摘要

The NIR-II/MRI NPs-Ate effectively reflected PD-L1 status during immunotherapy. Real-time and non-invasive immunotherapy and response/prognosis monitoring under NIR-II/MRI imaging guidance in TNBC is a promising and innovative technology with potential for extensive clinical applications in the future.

查看译文

关键词

immunotherapy,breast cancer,nir-ii/mri,dual-mode,triple-negative

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要